Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis
Related Experiment Video
Updated: Sep 29, 2026

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
1Faculty of Biology, University of Konstanz, Germany. Radek-Sedlacek@uni-konstanz.de
Abstract:
In order to characterize the autoimmune response participating in the pathogenesis of rheumatoid arthritis (RA) a cDNA expression library constructed from mRNAs which had been isolated from the inflamed synovium of an RA patients was screened with autologous IgG autoantibodies. This led to the identification of gene rasi-1 which encodes a protein showing sequence identity with the zinc-binding matrix metalloproteinase MMP-19. MMP-19 is detected on the surface of activated PBMCs, TH1 lymphocytes, and Jurkat T lymphoma cells. It exhibits gelatinolytic activity and is recognized by autoantibodies in 26% and, respectively, 33% of sera collected from RA patients and systemic lupus erythematosus (SLE) patients. The novel autoantigen MMP-19 thus could play a role in the pathological processes participating in RA-associated joint tissue destruction.
Insights
Researchers identified matrix metalloproteinase-19 (MMP-19) as a novel autoantigen in rheumatoid arthritis (RA). This protein, found on activated immune cells, is recognized by autoantibodies in RA and systemic lupus erythematosus (SLE) patients, potentially contributing to joint damage.
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Background:
- Rheumatoid arthritis (RA) pathogenesis involves complex autoimmune responses.
- Identifying specific autoantigens is crucial for understanding RA and developing targeted therapies.
Purpose of the Study:
- To characterize the autoimmune response in RA pathogenesis.
- To identify novel autoantigens involved in RA-associated joint tissue destruction.
Main Methods:
- Screening of a cDNA expression library from RA synovium with autologous IgG autoantibodies.
- Identification of gene rasi-1 encoding a protein with sequence identity to matrix metalloproteinase-19 (MMP-19).
- Detection of MMP-19 on activated peripheral blood mononuclear cells (PBMCs), TH1 lymphocytes, and Jurkat T lymphoma cells.
Main Results:
- MMP-19 was identified as a novel autoantigen.
- MMP-19 exhibits gelatinolytic activity.
- Autoantibodies against MMP-19 were detected in 26% of RA patient sera and 33% of systemic lupus erythematosus (SLE) patient sera.
Conclusions:
- MMP-19 is a novel autoantigen implicated in RA pathogenesis.
- MMP-19 may play a role in the joint tissue destruction associated with RA.
- The findings suggest MMP-19 as a potential target for diagnostic or therapeutic strategies in RA and SLE.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

